Cancer Medicine (Jul 2019)

A genetic variant in PIK3R1 is associated with pancreatic cancer survival in the Chinese population

  • Ying Zhu,
  • Juntao Ke,
  • Yajie Gong,
  • Yang Yang,
  • Xiating Peng,
  • Jianbo Tian,
  • Danyi Zou,
  • Nan Yang,
  • Xiaoyang Wang,
  • Shufang Mei,
  • Meilin Rao,
  • Pingting Ying,
  • Yao Deng,
  • Haoxue Wang,
  • Hongli Zhang,
  • Bin Li,
  • Hao Wan,
  • Yue Li,
  • Siyuan Niu,
  • Yimin Cai,
  • Ming Zhang,
  • Zequn Lu,
  • Rong Zhong,
  • Xiaoping Miao,
  • Jiang Chang

DOI
https://doi.org/10.1002/cam4.2228
Journal volume & issue
Vol. 8, no. 7
pp. 3575 – 3582

Abstract

Read online

Abstract Pancreatic cancer is one of the deadliest malignancies with few early detection tests or effective therapies. PI3K‐AKT signaling is recognized to modulate cancer progression. We previously identified that a genetic variant in PKN1 increased pancreatic cancer risk through the PKN1/FAK/PI3K/AKT pathway. In order to investigate the associations between genetic variations in that pathway and pancreatic cancer prognosis, we conducted a two‐stage survival analysis in a total of 547 Chinese pancreatic cancer patients. Consequently, a variant, rs13167294 A>C in PIK3R1, was significantly associated with poor survival in both stages and with hazard ratio being 1.32 (95% CI = 1.13‐1.56, P = 0.0007) in the combined analysis. Function annotation and prediction suggested that genetic variants in this locus might affect overall survival of pancreatic cancer patients by regulating PIK3R1 expression.

Keywords